Meanwhile, we found that the RSRC2 expression was lower in the chemotherapy non-responder than in the chemotherapy responder (Figure 3G) by using the Kaplan–Meier Plotter, suggesting that breast cancer with RSRC2 low expression was prone to drug resistance than RSRC2 high expression. Here, RSRC2 is linked to breast carcinoma.